Thank you for subscribing!
Next Investors Archived Dec 04, 2017
It has been a major month for Creso Pharma (ASX:CPH) as it continues to make potentially market moving announcements.
Next Investors Archived Nov 23, 2017
MGC Pharmaceuticals (ASX:MXC) was the second company to originally emerge in the ASX cannabis corridor, and with a whip-smart team that’s put in serious hours in the industry-leading Israeli medicinal marijuana scene, this ASX junior is rapidly coming into its own.
Finfeed Archived Nov 22, 2017
Creso Pharma Limited (ASX:CPH) today announced it had secured an important deal with its Australian distribution partner, Health House International, for the import and distribution of its first cannabinoid-based human health product.
Finfeed Archived Sep 25, 2017
Diversified investment group, Chapmans Limited (ASX:CHP), has announced the company’s successful completion of its strategic investment in MJ Life Sciences (MJLS).
Get expert stock analysis direct in your inbox
Finfeed Archived Aug 30, 2017
Diversified investment group, Chapmans (ASX: CHP) announced on Tuesday that it had entered into a binding Heads of Agreement (HOA) with MJ Life Sciences (MJLS) with a view to making a strategic investment of $500,000 in MJLS, an Australian special-purpose company established with the aim of becoming a leading global medicinal cannabis holding and investment company.
Catalyst Hunter Archived Aug 06, 2017
CPH is a leading player in medicinal cannabis and cannabidiol (CBD) innovation, and develops cannabis and hemp-derived therapeutic-grade CBD nutraceuticals and medicinal cannabis products with wide patient and consumer reach for both human and animal health.
Finfeed Archived Jul 28, 2017
Creso Pharma Limited (ASX: CPH) has expanded into the Canadian market with the proposed acquisition of emerging Nova Scotia-based medicinal cannabis producer, Mernova Medicinal Inc (Mernova) for a total of C$10.1 million (A$10.2 million) in cash and equity.
Next Investors Archived Jul 27, 2017
Creso Pharma (ASX:CPH) is now in the box seat to acquire 100% of Canadian-based Mernova Medicinal Inc., an acquisition that would position CPH as a Canadian producer of legal cannabis.
Finfeed Archived Jun 26, 2017
Diversified investment company focused on high-growth market segments, Chapmans (ASX: CHP) announced on Friday that its specialist wholly owned medicinal cannabis subsidiary, Cannabis Investments Limited (CIL), had entered into a Term Sheet with AZ Pharmaceuticals Inc., the owner of the Aunt Zelda’s medicinal cannabis business, to invest US$2 million in Aunt Zelda’s.
Join Our Mailing List
